August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
New Clinical Trial Explores WRN Helicase Inhibitor MOMA-341 in GI Cancers Resistant to Immunotherapy
Aug 16, 2025, 11:26

New Clinical Trial Explores WRN Helicase Inhibitor MOMA-341 in GI Cancers Resistant to Immunotherapy

Tiago Biachi de Castria, Medical Oncologist, Associate Member at Moffitt Cancer Center, Associate Professor at University of South Florida, shared a post on LinkedIn:

“Phase 1 trial with MOMA-341 is now open at Moffitt (NCT06974110)! This is a potent WRN helicase inhibitor with great preclinical activity in MSI-H tumors and a great option for our GI cancers patients with primary or acquired resistance to IO.”

Read further.

WRN Helicase Inhibitor

More posts featuring Tiago Biachi de Castria on OncoDaily.